Phenytoin/clonazepam interaction - PubMed

Case Reports

Phenytoin/clonazepam interaction

I N Saavedra et al. Ther Drug Monit. 1985.

Abstract

An interaction between phenytoin (PHT) and clonazepam (CZP) occurred in an epileptic patient, who had been treated with PHT with partial seizure control. The addition of CZP brought about a significant decrease of PHT plasma levels (from 24.8 to 16 micrograms/ml) in spite of increases in the PHT dose. Gradual reduction of CZP, without modifying the PHT dosage, caused significant increases in PHT plasma levels to 42.4 micrograms/ml with signs of intoxication. A review of the literature shows contradictions: some authors state that there is no interaction between the drugs; other authors state either an increase or decrease in PHT plasma levels. These paradoxical results could be explained by the bidirectional effect of these drugs in hepatic enzyme metabolism. The importance of monitoring plasma levels of antiepileptic drugs is emphasized when several medications are required in the treatment of epilepsy.

Similar articles

• Lack of effect of clonazepam on serum levels of diphenylhydantoin, phenobarbital and carbamazepine.

  Johannessen SI, Strandjord RE, Munthe-Kaas AW. Johannessen SI, et al. Acta Neurol Scand. 1977 Jun;55(6):506-12. doi: 10.1111/j.1600-0404.1977.tb07629.x. Acta Neurol Scand. 1977. PMID: 878840

• Clinical rules for phenytoin dosing.

  Privitera MD. Privitera MD. Ann Pharmacother. 1993 Oct;27(10):1169-73. doi: 10.1177/106002809302701001. Ann Pharmacother. 1993. PMID: 7818614 Clinical Trial.

• Carbamazepine-phenytoin interaction: elevation of plasma phenytoin concentrations due to carbamazepine comedication.

  Zielinski JJ, Haidukewych D, Leheta BJ. Zielinski JJ, et al. Ther Drug Monit. 1985;7(1):51-3. Ther Drug Monit. 1985. PMID: 3992622

• Drug interaction profile of topiramate.

  Bourgeois BF. Bourgeois BF. Epilepsia. 1996;37 Suppl 2:S14-S17. doi: 10.1111/j.1528-1157.1996.tb06028.x. Epilepsia. 1996. PMID: 8641241 Review.

Cited by

• Lamotrigine in children and adolescents: the impact of age on its serum concentrations and on the extent of drug interactions.

  Reimers A, Skogvoll E, Sund JK, Spigset O. Reimers A, et al. Eur J Clin Pharmacol. 2007 Jul;63(7):687-92. doi: 10.1007/s00228-007-0308-2. Epub 2007 May 12. Eur J Clin Pharmacol. 2007. PMID: 17497143

• Drug-Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications.

  Di Mizio G, Marcianò G, Palleria C, Muraca L, Rania V, Roberti R, Spaziano G, Piscopo A, Ciconte V, Di Nunno N, Esposito M, Viola P, Pisani D, De Sarro G, Raffi M, Piras A, Chiarella G, Gallelli L. Di Mizio G, et al. Int J Environ Res Public Health. 2021 Dec 8;18(24):12936. doi: 10.3390/ijerph182412936. Int J Environ Res Public Health. 2021. PMID: 34948545 Free PMC article. Review.

• Pharmacokinetic drug interactions with phenytoin (Part II).

  Nation RL, Evans AM, Milne RW. Nation RL, et al. Clin Pharmacokinet. 1990 Feb;18(2):131-50. doi: 10.2165/00003088-199018020-00004. Clin Pharmacokinet. 1990. PMID: 2180613 Review. No abstract available.

• Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations.

  Riva R, Albani F, Contin M, Baruzzi A. Riva R, et al. Clin Pharmacokinet. 1996 Dec;31(6):470-93. doi: 10.2165/00003088-199631060-00005. Clin Pharmacokinet. 1996. PMID: 8968658 Review.

• Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and Lamotrigine.

  Ku LC, Wu H, Greenberg RG, Hill KD, Gonzalez D, Hornik CP, Berezny A, Guptill JT, Jiang W, Zheng N, Cohen-Wolkowiez M, Melloni C. Ku LC, et al. Ther Drug Monit. 2016 Dec;38(6):728-737. doi: 10.1097/FTD.0000000000000354. Ther Drug Monit. 2016. PMID: 27764025 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.